Penn Center for Research on Coronavirus and Other Emerging Pathogens

In response to the global SARS-CoV-2 crisis, and in close consultation with leadership of the Perelman School of Medicine, we are excited to announce the founding of the Penn Center for Research on Coronaviruses and Other Emerging Pathogens.

The goals of the Center are to 1) Accelerate SARS-CoV-2 research under Biosafety Level 3 containment, 2) Provide centralized information on SARS-CoV-2 research at Penn, and 3) Compile information on funding opportunities for research on SARS-CoV-2 and other emerging pathogens.

The Center will be led by Susan Weiss and Frederic Bushman. A highly distinguished set of researchers from Penn, CHOP and Wistar have agreed to serve as our internal advisory board.

Already Penn researchers are expanding stocks of SARS-CoV-2 and beginning studies of viral replication and inhibition. The Center is working to expand these efforts and to create new research opportunities in this area.

It is gratifying to see how rapidly the Penn community has come together to address this global health crisis. We have much to do.

Internal Advisory Board

Funding Sources

Papers on Coronaviruses from the Penn Community

Join our listserv and tell us about your research project!



A single and two-stage, closed-tube, molecular test for the 2019 novel coronavirus at home, clinic, and points of entry, El-Tholoth, Bau and Song, in “ChemRxiv”

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2, Liu, Saif, Weiss and Su, “Emerging Microbes and Infections”


Lecture tomorrow on Monkeypox and beyond! The talk will be targeted to all interested listeners, not just specialists. Stu Isaacs is a great speaker—please attend!

Congrats to Kee, Weiss, Korb and coworkers on their Nature paper describing how SARS-CoV-2 disrupts epigenetic regulation. Viral Orf8 functions as a histone mimic. Check out the paper and news article: PMID: 36198800; PMID: 36198813.

Excited to announce an upcoming talk by Stu Isaacs on poxvirus diseases in the modern world. The talk will be for both nonspecialists and specialists. Please RT!

Congrats to Carter Merenstein et al. for publishing a review of 56 studies (!!) of COVID and the microbiome. Particularly strong signal in lineages declining in abundance with disease severity. Check it out! PMID: 36195943

Christie's just sold NFT art based on the Weissman/Kariko modified mRNA technology for $226,800. Proceeds to benefit biomedical research. Congrats to all involved!

Member Login